ISSN:
1468-3083
Source:
Blackwell Publishing Journal Backfiles 1879-2005
Topics:
Medicine
Notes:
Background Kaposi's sarcoma (KS) is the most common neoplasm in patients with AIDS: in some cohorts of homosexual men with AIDS, the lifetime risk of KS approaches 50%. Prognosis is either ‘good risk’ or ‘poor risk’ according to recommended staging criteria.Objective In the present study we treated a good risk AIDS-KS group of patients with low dose of alpha-2 interferon (alpha-21FN) plus AZT, and a poor risk AIDS-KS group of patients with chemotherapy.Study design Prospective, non-randomized trial.Subjects Forty-four homosexual or bisexual male patients between 21 and 45 years old with positive ELISA for HIV, and KS, were included in the study.Intervention Ten patients received alpha-2 1FN plus AZT, 12 bleomycin, 12 doxorubicin-bleomycin-vincristine (ABV), and ten patients did not receive treatment.Results One patient achieved complete remission, two partial remission (PR), six stable disease (SD) and one progression (P) during alpha-2 IFN plus AZT treatment. Seven patients showed SD and five P during bleomycin treatment; and four patients achieved PR and eight SD during ABV treatment.Outcome Despite the fact that the different systemic treatment modalities employed allowed us to achieve clinical responses, there was no significant improvement in survival.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1111/j.1468-3083.1997.tb00226.x
Permalink